Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: And some still think S&L is our enemy....

Perhaps an M&A involving stock could be a possibility seeing as we acquired a company on loan forclosure.

Re-reading the warrant buyback program is interesting and I wonder if the share repurchase plan was a way to offset the fulfillment of the warrant plan.

http://ptsc.com/news/press_releases/20060210.asp

Share
New Message
Please login to post a reply